Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials (Q34534666)

2 August 2017

1 reference

title

Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials (English)

1 reference

2 August 2017

1 reference

1 reference

Gershlick AH

1

1 reference

2 August 2017

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

160

1 reference

2 August 2017

2

1 reference

2 August 2017

259-271

1 reference

Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Vascular events responsible for thrombotic occlusion of a blood vessel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Young infarct patients with single-vessel occlusion do not have an underlying prothrombotic state to explain their coronary occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

A time sequence of vessel wall changes in an experimental model of angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Histologic analysis of directional coronary atherectomy samples. A review of findings and their clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Coronary stenting with a novel stainless steel balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Three-year clinical follow-up after Palmaz-Schatz stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Can early closure and restenosis after endoluminal stenting be predicted from clinical, procedural, and angiographic variables at the time of intervention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Thrombosis and restenosis after stenting in failed angioplasty: comparison with elective stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Effect of prior coronary restenosis on the risk of subsequent restenosis after stent placement or directional atherectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience. The U.S. Palmaz-Schatz Stent Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Restenosis revisited: insights provided by quantitative coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Suppression by heparin of smooth muscle cell proliferation in injured arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

The Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Intracoronary heparin delivery in humans. Acute feasibility and long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

The Dispatch catheter as a delivery tool for arterial gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

A targeted antithrombotic conjugate with antiplatelet and fibrinolytic properties which reduces in vivo thrombus formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Adverse long-term effects of reocclusion after coronary thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Histopathology of in-stent restenosis in patients with peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Catheter-based radiotherapy to inhibit restenosis after coronary stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Late coronary occlusion after intracoronary brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Preparation, characterization, and evaluation of a monoclonal antibody against the rabbit platelet glycoprotein IIb/IIIa in an experimental angioplasty model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900618-9

10.1016/S0021-9150(01)00618-9

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11849647